Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/21650799241286039 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical Manifestations.
Alzheimers Dement
December 2024
FTD Disorders Registry, King of Prussia, PA, USA.
Background: Frontotemporal degeneration (FTD) is a complex, heterogeneous group of fatal adult-onset disorders which lead to progressive dysfunction in behavior, motor symptoms, language, and/or cognition. While advances in research are cause for optimism, trials are hindered by the availability of participants. As FTD clinical trials typically require co-participation of a study partner, care partner perspectives on research are critical to understanding how to support recruitment and retention.
View Article and Find Full Text PDFClinical Manifestations.
Alzheimers Dement
December 2024
Unidad de diagnóstico de deterioro cognitivo y prevención de demencia, Instituto Peruano de Neurociencias, Lima, Perú, Lima, Lima, Peru.
Background: People caring of individuals with dementia are prone to suffering from burden. Behavioral and psychological symptoms of dementia (BPSD) may have an impact on caregiver burden. In Latin American countries there is lack of research on caregiver burden.
View Article and Find Full Text PDFClinical Manifestations.
Alzheimers Dement
December 2024
NIA-Layton Aging & Alzheimer's Disease Research Center, Portland, OR, USA.
Background: Agitation is one of the most challenging behaviors exhibited by people with cognitive decline, causing distress in caregivers, earlier placement into long-term care and faster disease progression. In order to better manage agitated behaviors in people with cognitive decline, it is important to identify associated factors. The MODERATE (Monitoring Dementia-Related Agitation Using Technology Evaluation) study aims to characterize agitation using technology and identify precipitants (behavioral or environmental) of agitation.
View Article and Find Full Text PDFAdvancing Health Equity Metrics: Estimating the Burden of Lung Cancer Attributed to Known Carcinogens by Socio-economic Position.
Am J Epidemiol
December 2024
Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000 Rennes, France.
Attributable burden of disease estimates reported population-wide do not reflect social disparities in exposures and outcomes. This makes one of the influential scientific tools in public health decision-making insensitive to the distribution of health impacts between socioeconomic groups. Our aim was to use the often-overlooked distributive property of the population attributable fraction (PAF) to quantitatively partition the population burden attributed to know risk factors into subgroups defined by their socioeconomic position (SEP).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!